Sabine C Linn (Sabine Linn, S C Linn)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Topics

Positive Breast Cancer

Estrogen Receptor

Endoplasmic Reticulum

Top Venues

Genome research

International journal of cancer

NPJ breast cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Christine Donaldson, Tunç Morova, Umut Berkay Altintas, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions. Genome research 34 (4) (2024)
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Christine Donaldson, Tunç Morova, Umut Berkay Altintas, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions. Genome research (2024)
Iris Nederlof, Olga I Isaeva, Manon de Graaf, Robbert C A M Gielen, Noor A M Bakker, Adrianne L Rolfes, Hannah Garner, Bram Boeckx, Joleen J H Traets, Ingrid A M Mandjes, Michiel de Maaker, Thomas van Brussel, Maksim A Chelushkin, Elisa Champanhet, Marta Lopez-Yurda, Koen K van de Vijver, José G van den Berg, Ingrid Hofland, Natasja Klioueva, Ritse M Mann, Claudette E Loo, Frederieke H van Duijnhoven, Victoria Skinner, Sylvia Luykx, Emile Kerver, Ekaterina Kalashnikova, Marloes G J van Dongen, Gabe S Sonke, Sabine C Linn, Christian U Blank, Karin E de Visser, Roberto Salgado, Lodewyk F A Wessels, Caroline A Drukker, Ton N M Schumacher, Hugo Mark Horlings, Diether Lambrechts, Marleen Kok
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial. Nature medicine (2024)
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Christine Donaldson, Tunç Morova, Umut Berkay Altintas, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions. Genome research 34 (4) (2024)
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Christine Donaldson, Tunç Morova, Umut Berkay Altintas, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions. Genome research 34 (4) (2024)
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Christine Donaldson, Tunç Morova, Umut Berkay Altintas, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions. Genome research 34 (4) (2024)
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Christine Donaldson, Tunç Morova, Umut Berkay Altintas, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions. Genome research 34 (4) (2024)
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Christine Donaldson, Tunç Morova, Umut Berkay Altintas, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions. Genome research 34 (4) (2024)
Stacey E P Joosten, Sebastian Gregoricchio, Suzan Stelloo, Elif Yapıcı, Chia-Chi Flora Huang, Kerim Yavuz, Maria Christine Donaldson, Tunç Morova, Umut Berkay Altintas, Yongsoo Kim, Sander Canisius, Cathy B Moelans, Paul J van Diest, Gozde Korkmaz, Nathan A Lack, Michiel Vermeulen, Sabine C Linn, Wilbert Zwart
Estrogen receptor 1 chromatin profiling in human breast tumors reveals high inter-patient heterogeneity with enrichment of risk SNPs and enhancer activity at most-conserved regions. Genome research 34 (4) (2024)
Leonie Voorwerk, Joyce Sanders, Milou S Keusters, Sara Balduzzi, Sten Cornelissen, Maxime Duijst, Esther H Lips, Gabe S Sonke, Sabine C Linn, Hugo Mark Horlings, Marleen Kok
Immune landscape of breast tumors with low and intermediate estrogen receptor expression. NPJ breast cancer 9 (1) (2023)
Sonja B Vliek, Florentine S Hilbers, Erik D van Werkhoven, Ingrid Mandjes, Rob Kessels, Sieta Kleiterp, Esther H Lips, Lennart Mulder, Mutamba T Kayembe, Claudette E Loo, Nicola S Russell, Marie-Jeanne T F D Vrancken Peeters, Marjo J Holtkamp, Margaret Schot, Joke W Baars, Aafke H Honkoop, Annelie J E Vulink, Alex L T Imholz, Suzan Vrijaldenhoven, Franchette W P J van den Berkmortel, Jetske M Meerum Terwogt, Jolanda G Schrama, Philomeen Kuijer, Judith R Kroep, Annemieke van der Padt-Pruijsten, Jelle Wesseling, Gabe S Sonke, Kenneth G A Gilhuijs, Agnes Jager, Petra M Nederlof, Sabine C Linn
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial. NPJ breast cancer 9 (1) (2023)
Leonie Voorwerk, Olga I Isaeva, Hugo Mark Horlings, Sara Balduzzi, Maksim Chelushkin, Noor A M Bakker, Elisa Champanhet, Hannah Garner, Karolina Sikorska, Claudette E Loo, Inge Kemper, Ingrid A M Mandjes, Michiel de Maaker, Jasper J L van Geel, Jorianne Boers, Maaike de Boer, Roberto Salgado, Marloes G J van Dongen, Gabe S Sonke, Karin E de Visser, Ton N M Schumacher, Christian U Blank, Lodewyk F A Wessels, Agnes Jager, Vivianne C G Tjan-Heijnen, Carolien P Schröder, Sabine C Linn, Marleen Kok
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. Nature cancer (2023)
Leonie Voorwerk, Joyce Sanders, Milou S Keusters, Sara Balduzzi, Sten Cornelissen, Maxime Duijst, Esther H Lips, Gabe S Sonke, Sabine C Linn, Hugo Mark Horlings, Marleen Kok
Immune landscape of breast tumors with low and intermediate estrogen receptor expression. NPJ breast cancer 9 (1) (2023)
Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao, Sjoerd Klarenbeek, Mark Opdam, Yuval Malka, Liesbeth Hoekman, Dinja T Kruger, Onno B Bleijerveld, Chiara S Brambillasca, Justin Sprengers, Bjorn Siteur, Stefano Annunziato, Matthijs J van Haren, Nathaniel I Martin, Marieke van de Ven, Dennis Peters, Reuven Agami, Sabine C Linn, Epie Boven, A F Maarten Altelaar, Jos Jonkers, Daniel Zingg, Lodewyk F A Wessels
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer. The Journal of experimental medicine 220 (11) (2023)
Leonie Voorwerk, Joyce Sanders, Milou S Keusters, Sara Balduzzi, Sten Cornelissen, Maxime Duijst, Esther H Lips, Gabe S Sonke, Sabine C Linn, Hugo Mark Horlings, Marleen Kok
Immune landscape of breast tumors with low and intermediate estrogen receptor expression. NPJ breast cancer 9 (1) (2023)
Leonora W de Boo, Katarzyna Jóźwiak, Heikki Joensuu, Henrik Lindman, Susanna Lauttia, Mark Opdam, Charlaine van Steenis, Wim Brugman, Roelof J C Kluin, Philip C Schouten, Marleen Kok, Petra M Nederlof, Michael Hauptmann, Sabine C Linn
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients. British journal of cancer 126 (10) (2022)
Vincent M T de Jong, Yuwei Wang, Natalie D Ter Hoeve, Mark Opdam, Nikolas Stathonikos, Katarzyna Jóźwiak, Michael Hauptmann, Sten Cornelissen, Willem Vreuls, Efraim H Rosenberg, Esther A Koop, Zsuzsanna Varga, Carolien H M van Deurzen, Antien L Mooyaart, Alicia Córdoba Iturriagagoitia, Emma J Groen, Joost Bart, Stefan M Willems, Vasiliki Zolota, Jelle Wesseling, Anna Sapino, Ewa Chmielik, Aleš Ryška, Annegien Broeks, Adri C Voogd, Sherene Loi, Stefan Michiels, Gabe S Sonke, Elsken van der Wall, Sabine Siesling, Paul J van Diest, Marjanka K Schmidt, Marleen Kok, Gwen M H E Dackus, Roberto Salgado, Sabine C Linn
Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Sonja B Vliek, Iris Noordhoek, Elma Meershoek-Klein Kranenbarg, Annelot G J van Rossum, Vincent O Dezentje, Agnes Jager, J W Esmeralda Hokken, Hein Putter, Annette W G van der Velden, Marieke H J van den Beuken-van Everdingen, Sandra D Bakker, Yvonne E A van Riet, Vivianne C G Tjan-Heijnen, Johanneke E A Portielje, Judith R Kroep, Johan W R Nortier, Cornelis J H van de Velde, Sabine C Linn
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor-Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Simone N Koole, Philip C Schouten, Jan Hauke, Roel J C Kluin, Petra Nederlof, Lisa K Richters, Gabriele Krebsbach, Karolina Sikorska, Maartje Alkemade, Mark Opdam, Jules H Schagen van Leeuwen, Henk W R Schreuder, Ralph H M Hermans, Ignace H J T de Hingh, Constantijne H Mom, Henriette J G Arts, Maaike van Ham, Peter van Dam, Peter Vuylsteke, Joyce Sanders, Hugo M Horlings, Koen K van de Vijver, Eric Hahnen, Willemien J van Driel, Rita Schmutzler, Gabe S Sonke, Sabine C Linn
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial. International journal of cancer 151 (8) (2022)
M Opdam, V van der Noort, M Kleijn, A Glas, I Mandjes, S Kleiterp, F S Hilbers, D T Kruger, A D Bins, P C de Jong, P P J B M Schiphorst, T van Dalen, B Flameling, R C Rietbroek, A Beeker, S M van den Heiligenberg, S D Bakker, A N M Wymenga, I M Oving, R M Bijlsma, P J van Diest, J B Vermorken, H van Tinteren, Sabine C Linn
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature. Breast cancer research and treatment 194 (2) (2022)
Simone N Koole, Philip C Schouten, Willemien J van Driel, Gabe S Sonke, Sabine C Linn
Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial". International journal of cancer 151 (11) (2022)
Gwen M H E Dackus, Katarzyna Jóźwiak, Gabe S Sonke, Elsken van der Wall, Paul J van Diest, Sabine Siesling, Michael Hauptmann, Sabine C Linn
Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients. Journal of the National Cancer Institute 113 (11) (2022)
Jill J J Geenen, Gwen M H E Dackus, Philip C Schouten, Dick Pluim, Serena Marchetti, Gabe S Sonke, Katarzyna Jóźwiak, Alwin D R Huitema, Jos H Beijnen, Jan H M Schellens, Sabine C Linn
A Phase I dose-escalation study of two cycles carboplatin-olaparib followed by olaparib monotherapy in patients with advanced cancer. International journal of cancer 148 (12) (2021)
Tessa G Steenbruggen, Michael Schaapveld, Hugo Mark Horlings, Joyce Sanders, Sander J Hogewoning, Esther H Lips, Marie-Jeanne T Vrancken Peeters, Niels F Kok, Terry Wiersma, Laura J Esserman, Laura J van 't Veer, Sabine C Linn, Sabine Siesling, Gabe S Sonke
Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer. JNCI cancer spectrum 5 (3) (2021)
Daniël J van der Meer, Iris Kramer, Marissa C Van Maaren, Paul J van Diest, Sabine C Linn, John H Maduro, Luc J A Strobbe, Sabine Siesling, Marjanka K Schmidt, Adri C Voogd
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017. International journal of cancer 148 (9) (2020)
Gwen M H E Dackus, Katarzyna Jóźwiak, Elsken van der Wall, Paul J van Diest, Michael Hauptmann, Sabine Siesling, Gabe S Sonke, Sabine C Linn
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer. Breast cancer research and treatment 185 (3) (2020)
Dinja T Kruger, Xanthippi Alexi, Mark Opdam, Karianne Schuurman, Leonie Voorwerk, Joyce Sanders, Vincent van der Noort, Epie Boven, Wilbert Zwart, Sabine C Linn
IGF-1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER-positive breast cancer. International journal of cancer 146 (8) (2019)
Karin Beelen, Mark Opdam, Tesa Severson, Rutger Koornstra, Andrew Vincent, Jelle Wesseling, Joyce Sanders, Jan Vermorken, Paul van Diest, Sabine C Linn
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot. BMC cancer 18 (1) (2018)